FDA Adverse Event Injury Summary report: N

INFUSOMAT®

MDR report key: 7567166 · Received June 4, 2018

Report

Report Number
9610825-2018-00094
Event Type
Injury
Date Received
June 4, 2018
Date of Event
April 11, 2018
Report Date
July 27, 2018
Manufacturer
B. BRAUN MELSUNGEN AG
Product Code
FRN
UDI-DI
04046963716752
PMA / PMN Number
K083689
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
IN, US
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 0

EXEMPTION NUMBER E2016018 . B. BRAUN INC. (BBMI) (IMPORTER) IS SUBMITTING THE REPORT ON BEHALF OF B. BRAUN MELSUNGEN AG (MANUFACTURER). THIS REPORT HAS BEEN IDENTIFIED AS B. BRAUN MEDICAL INC. INTERNAL REPORT NUMBER (B)(4). THE PUMP INVOLVED IN THE INCIDENT WAS NOT RETURNED FOR EVALUATION, HOWEVER THE DEVICE HISTORY LOGS WERE PROVIDED BY THE USER FACILITY. THE LOG REVIEW SHOWED THAT THE CALCULATED VOLUME INFUSED VERSUS THE EXPECTED VOLUME TO BE DELIVERED WAS WITHIN SPECIFICATION. BASED ON INFORMATION FROM THE USER FACILITY, THE PUMP FUNCTIONED AS INTENDED BY RETURNING TO THE PRIMARY INFUSION ONCE THE SECONDARY INFUSION HAD COMPLETED. THE MOST LIKELY ROOT CAUSE FOR THE PATIENT RECEIVING AN UNINTENDED DOSE OF INSULIN WAS THAT INSULIN WAS SET AS THE PRIMARY INFUSION WITH FLUIDS SET AS THE SECONDARY INFUSION, INSTEAD OF THE OTHER WAY AROUND TO USE THE INSULIN ONLY AS A BOLUS. NO ADVERSE QUALITY TRENDS OF THIS NATURE WERE IDENTIFIED DURING THE COMPLAINT REVIEW PROCESS FOR THE REPORTED CATALOG NUMBER. IF ADDITIONAL INFORMATION BECOMES AVAILABLE, A FOLLOW UP REPORT WILL BE SUBMITTED.

Additional Manufacturer Narrative · 0

EXEMPTION NUMBER E2016018 B. BRAUN INC. (BBMI) (IMPORTER) IS SUBMITTING THE REPORT ON BEHALF OF B. BRAUN MELSUNGEN AG (MANUFACTURER). THIS REPORT HAS BEEN IDENTIFIED AS B. BRAUN MEDICAL INC. INTERNAL REPORT NUMBER (B)(4). THE INVESTIGATION INTO THIS REPORTED EVENT IS ONGOING. A COPY OF THE DEVICE LOGS HAS BEEN PROVIDED TO B. BRAUN FOR REVIEW TO VERIFY THE FACILITY'S DETERMINATION THAT THIS INCIDIENT WAS NOT THE RESULT OF A PUMP MALFUNCTION. A FOLLOW-UP REPORT WILL BE SUBMITTED WHEN THE RESULTS OF THE INVESTIGATION ARE AVAILABLE.

Description of Event or Problem · 0

AS REPORTED BY USER FACILITY: PATIENT RECEIVED OVER INFUSION OF INSULIN. THE PUMP WAS SET TO RUN A PRIMARY AND A SECONDARY INFUSION, AND WHEN A BOLUS OF THE FLUID INFUSION WAS GIVEN, THE PUMP ALSO ADMINISTERED A BOLUS OF THE INSULIN. ALTHOUGH NO PATIENT INJURY WAS OBSERVED, MEDICAL PERSONNEL INTERVENED WITH DEXTROSE 50%. THE FACILITY'S BIOMED DEPARTMENT EVALUATED THE PUMP AND DETERMINED THAT THE PUMP WAS WORKING CORRECTLY. THE FACILITY BELIEVES THE OVER INFUSION WAS THE RESULT OF USER ERROR, OR INCORRECT PROGRAMMING OF THE DRUG LIBRARY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
408705 INFUSOMAT® PUMP, INFUSION FRN B. BRAUN MELSUNGEN AG 04046963716752

Patients

Seq Age Sex Outcome Treatment
1 28 YR Required Intervention